Peter C. Wulff
Keine laufenden Positionen mehr
Profil
Peter C.
Wulff served as Chief Financial Officer & Treasurer at Natural Alternatives International, Inc. from 1999 to 2001.
He was also the CFO, Treasurer, VP & Assistant Secretary at CryoCor, Inc. from 2001 to 2004, and the Chief Financial Officer & Executive Vice President at Artes Medical, Inc. from 2005 to 2008.
From 2008 to 2011, he served as Senior Vice President-Strategic Initiatives at Alphatec Holdings, Inc. He was also the Chief Financial Officer, Treasurer & VP at Alphatec Spine, Inc. from 2008 to 2010.
In addition, he was the Secretary, Chief Operating & Financial Officer at PURE Bioscience, Inc. from 2013 to 2015, and the Chief Financial Officer & Vice President at Agendia NV in 2012-2013.
He is currently serving as the Chief Financial Officer at JenaValve Technology, Inc. since 2015.
Before his career in finance, he completed his undergraduate and MBA degrees from Indiana University.
Ehemalige bekannte Positionen von Peter C. Wulff
| Unternehmen | Position | Ende |
|---|---|---|
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Finanzdirektor/CFO | 10.05.2022 |
| PURE BIOSCIENCE, INC. | Finanzdirektor/CFO | 31.07.2015 |
| ALPHATEC HOLDINGS, INC. | Corporate Officer/Principal | 01.04.2011 |
Alphatec Spine, Inc.
 Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Alphatec Spine, Inc. is focused on the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders, with a focus on treating condition affecting the aging spine. The firms product portfolio and pipeline include spinal disorder products and systems. The company was founded in 1990 and is headquartered in Carlsbad, CA. | Finanzdirektor/CFO | 11.10.2010 |
Artes Medical, Inc.
 Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | Finanzdirektor/CFO | 12.05.2008 |
Ausbildung von Peter C. Wulff
| Indiana University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL, INC. | Health Technology |
| PURE BIOSCIENCE, INC. | Process Industries |
| ALPHATEC HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
IMED Corp
 IMED Corp Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., IMED Corp is a surgical and medical instruments company. The company is based in San Diego, CA. IMED was acquired by CareFusion 303, Inc. on October 18, 1993. | Health Technology |
CryoCor, Inc.
 CryoCor, Inc. Medical SpecialtiesHealth Technology CryoCor, Inc. provided medical technology services. It developed and manufactured a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The firm's product the CryoCor Cardiac Cryoablation System, was designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The company was founded in 2000 and was headquartered in San Diego, CA. | Health Technology |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | Finance |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
Alphatec Spine, Inc.
Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Alphatec Spine, Inc. is focused on the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders, with a focus on treating condition affecting the aging spine. The firms product portfolio and pipeline include spinal disorder products and systems. The company was founded in 1990 and is headquartered in Carlsbad, CA. | Health Technology |
| Acumen Biomedical | |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Health Technology |
